Oncotarget – Maximum Impact Oncology Journal

Open Access Oncology Journal

OncoTarget is an open access Oncology journal which has a very broad scope. In the years 2016-2017, the journal had an impact factor of 5168 according to Reuters JCR. The journal focuses specifically on cancer research and topics related to oncology. Tumor development is a complex topic, meaning that there is plenty of research that comes out of this journal related to the process.

Sections Of The Journal

The journal has a section on aging research called GeroTarget, which is designed to publish research in that field. This comes in addition to a pathology section which offers a higher impact factor than many of the other sections of the journal. The immunology and microbiology section covers the immune responses to cancerous cells. This section of the journal is also known for rapid publication of papers within just a few days of submission. The Autophagy and Cell Death section publishes papers related to cellular signaling and cell-death research. The chromosome section of the paper is for researchers whom are interested in concepts of cell division/heredity as it relates to the development of cancers.

Online Submission System For Submitting Papers

The OncoTarget journal features a submission page which allows authors to submit papers. This system allows individual researchers to set up an online account to begin the process of submitting an article. Once a prospective author creates an account, the author is then able to follow through with the instructions to be able to submit a manuscript.

High Standard Of Publication Ethics ON the Part Of the Journal

Generally speaking, the journal follows the Committee For Publication Ethics’ ethical guidelines. This ensures the appropriate level of cooperation between the journal and the research institutions which the journal has formed a partnership with. The publication asks that authors provide an accurate description of the results that they are able to obtain, along with a description of how they were able to obtain those results. This should be a highly accurate description that ensures the work is able to be replicated in a laboratory setting. Raw data is also helpful in cases where editorial review of the work in question might be required. Work should also be original, and should not be submitted to multiple journals. Conflicts of interest should also be disclosed at the time of submission.

Relatively Open Licensing Format

The journal’s articles and content are licensed out with the Creative Commons license. This means that no permission is required for anyone to re-use the content of the journal. This licensing scheme does still provide authors with the ability to retain the copyright for their works. Attribution is provided via a citation to the original article published in OncoTarget. The names listed in the citation depend on the policies of the institution of the researcher citing an article. The aim of the journal is to make research that is published within it accessible, and this format contributes greatly in that manner.

Leave a Reply

Your email address will not be published. Required fields are marked *